$MDB

Cantor Fitzgerald Raises MongoDB (MDB) Price Target on Stable Outlook and AI Demand

Cantor Fitzgerald analyst Thomas Blakey raised MongoDB’s (MDB) price target to $416 from $378 and kept an Overweight rating, citing channel checks showing last quarter’s results were broadly in line and a stable forward outlook supported by AI demand. Separately, BMO Capital analyst Keith Bachman lifted his target to $360 from $285 with an Outperform rating, saying MongoDB is well positioned for durable long-term growth in AI workloads.

Original reporting
Published May 30, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 30, 2026, 3:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cantor Fitzgerald Raises MongoDB (MDB) Price Target on Stable Outlook and AI Demand — source image
Decision brief

The 30-second read

$MDBBullishMed
01

Why it matters

Re-rating via higher price targets can influence short-term positioning and options flows, but the underlying signal is stability rather than acceleration.

02

Market read

For MDB traders, the actionable element is the incremental bullish sell-side framing around AI-driven growth with stable outlook.

03

What to watch

Channel checks being “broadly in line” suggests no major beat; competitive positioning (e.g., Postgres use-case overlap) could cap multiple expansion.

Relevance 8/10Novelty 4/10Timing: pre-market today (published 2026-05-30)

Background

The piece summarizes two recent analyst actions (Cantor Fitzgerald on May 26 and BMO Capital on May 15) tied to MongoDB’s AI-related demand outlook.

Company-level read

Ticker impact

$MDBBullishMedium confidence
Context

Cantor Fitzgerald raised MongoDB’s price target to $416 from $378 on stable outlook and AI-driven demand.

Expected impact

Mild positive bias for MDB as analysts’ target increases can attract incremental dip-buying, though magnitude likely limited without new company-specific datapoints.

Evidence & confidence

The article is based on analyst target changes and channel checks broadly in line, not a new earnings print, contract, or guidance update from MongoDB itself.

Market effects

Supports the broader narrative that database vendors can benefit from AI workload adoption.

Primarily US tech/AI software sentiment; limited direct regional transmission.

AI infrastructure demand remains a global theme, but this is analyst-driven rather than a global macro shock.

Counterpoint

Analyst target increases may already be partially priced in; without a fresh MongoDB-specific catalyst, upside may fade quickly.

Key entities

  • MongoDB, Inc.

    Developer data platform; analyst target raises cite stable forward outlook and AI demand.

  • Cantor Fitzgerald

    Raised MDB price target to $416 from $378; maintained Overweight.

  • BMO Capital Markets

    Raised MDB price target to $360 from $285; kept Outperform.

Related articles

$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

$MDBMedAI 9/10

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.

$MDBMedAI 9/10

MongoDB (MDB) Stock Trades Up, Here Is Why

MongoDB shares rose 17.9% in the afternoon after its May 28 earnings beat and a broader software-sector rotation, according to the article. For Q1 FY2027, revenue was $687.6M (+25% YoY) vs. $664.5M expected; adjusted EPS was $1.32 vs. $1.19. Atlas revenue grew 29.4% to $512.5M; free cash flow was $197.5M. Guidance was raised to $2.92–$2.96B revenue and $5.95–$6.14 EPS.

$SNOWMedAI 9/10

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.